Combined measure of pro- and anti-oxidant exposures in relation to prostate cancer and colorectal adenoma risk: an update.
Ann Epidemiol., Dec;20(12):955-7 (2010)
A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on markers of their metabolism in normal mucosa of colorectal adenoma patients.
Cancer Res., Jan;71(2):413-23 (2011)
Semiparametric estimation for joint modeling of colorectal cancer risk and functional biomarkers measured with errors.
Biom J., May;53(3):393-410 (2011)
Clinical trials of antioxidants as cancer prevention agents: past, present, and future.
Free Radic. Biol. Med., Sep;51(5):1068-84 (2011)
Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: a randomized, controlled clinical trial.
Cancer Prev Res (Phila)., Oct;4(10):1645-54 (2011)
A summary measure of pro- and anti-oxidant exposures and risk of incident, sporadic, colorectal adenomas.
Cancer Causes Control., Dec;19(10):1051-64 (2008)
Association between adherence to the Mediterranean diet and oxidative stress.
Am. J. Clin. Nutr., Nov;88(5):1364-70 (2008)
TGF-alpha expression as a potential biomarker of risk within the normal-appearing colorectal mucosa of patients with and without incident sporadic adenoma.
Cancer Epidemiol. Biomarkers Prev., Jan;18(1):65-73 (2009)
Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, double-blind, placebo-controlled clinical trial.
Cancer Prev Res (Phila)., Mar;2(3):213-23 (2009)
Serum folate and cancer mortality among U.S. adults: findings from the Third National Health and Nutritional Examination Survey linked mortality file.
Cancer Epidemiol. Biomarkers Prev., May;18(5):1439-47 (2009)
Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer.
Annu. Rev. Nutr., 29:111-32 (2009)
MutL-homolog 1 expression and risk of incident, sporadic colorectal adenoma: search for prospective biomarkers of risk for colorectal cancer.
Cancer Epidemiol. Biomarkers Prev., May;18(5):1599-609 (2009)
Colorectal mucosal expression of MSH2 as a potential biomarker of risk for colorectal neoplasms.
Cancer Epidemiol. Biomarkers Prev., Nov;18(11):2965-73 (2009)
Robust statistical methods for analysis of biomarkers measured with batch/experiment-specific errors.
Stat Med., Feb;29(3):361-70 (2010)
Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial.
Cancer Epidemiol. Biomarkers Prev., Jan;19(1):280-91 (2010)
Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: results from a randomized, controlled clinical trial.
Cancer Epidemiol. Biomarkers Prev., Mar;19(3):850-8 (2010)
Vitamin D status and impact of vitamin D3 and/or calcium supplementation in a randomized pilot study in the Southeastern United States.
J Am Coll Nutr., Dec;28(6):678-86 (2009)
Blood 25-hydroxyvitamin D3 concentrations and incident sporadic colorectal adenoma risk: a pooled case-control study.
Am. J. Epidemiol., Sep;172(5):489-500 (2010)
Lycopene intake and prostate cancer risk: effect modification by plasma antioxidants and the XRCC1 genotype.
Nutr Cancer., 55(1):13-20 (2006)
Hypothesis: oxidative stress score as a combined measure of pro-oxidant and antioxidant exposures.
Ann Epidemiol., May;17(5):394-9 (2007)